Follow this preprint
Potency and Breadth of Neutralization after 3 doses of mRNA vaccines in COVID-19 Convalescent and Naïve individuals
Joanna Luczkowiak, Gonzalo Rivas, Nuria Labiod, Fátima Lasala, Marta Rolo, Jaime Lora-Tamayo, Mikel Mancheno-Losa, David Rial-Crestelo, Alfredo Pérez-Rivilla, María D. Folgueira, Rafael Delgado
doi: https://doi.org/10.1101/2022.03.17.22272557
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Joanna Luczkowiak
1Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain
Gonzalo Rivas
2Department of Microbiology. Hospital Universitario 12 de Octubre, Madrid, Spain
Nuria Labiod
1Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain
Fátima Lasala
1Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain
Marta Rolo
2Department of Microbiology. Hospital Universitario 12 de Octubre, Madrid, Spain
Jaime Lora-Tamayo
3Department of Internal Medicine. Hospital Universitario 12 de Octubre, Madrid, Spain
4CIBER de Enfermedades Infecciosas (CIBERINFEC - Instituto de Salud Carlos III)
Mikel Mancheno-Losa
3Department of Internal Medicine. Hospital Universitario 12 de Octubre, Madrid, Spain
David Rial-Crestelo
3Department of Internal Medicine. Hospital Universitario 12 de Octubre, Madrid, Spain
Alfredo Pérez-Rivilla
2Department of Microbiology. Hospital Universitario 12 de Octubre, Madrid, Spain
5School of Medicine. Universidad Complutense. Madrid, Spain
María D. Folgueira
1Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain
2Department of Microbiology. Hospital Universitario 12 de Octubre, Madrid, Spain
5School of Medicine. Universidad Complutense. Madrid, Spain
Rafael Delgado
1Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain
2Department of Microbiology. Hospital Universitario 12 de Octubre, Madrid, Spain
4CIBER de Enfermedades Infecciosas (CIBERINFEC - Instituto de Salud Carlos III)
5School of Medicine. Universidad Complutense. Madrid, Spain

Posted March 20, 2022.
Potency and Breadth of Neutralization after 3 doses of mRNA vaccines in COVID-19 Convalescent and Naïve individuals
Joanna Luczkowiak, Gonzalo Rivas, Nuria Labiod, Fátima Lasala, Marta Rolo, Jaime Lora-Tamayo, Mikel Mancheno-Losa, David Rial-Crestelo, Alfredo Pérez-Rivilla, María D. Folgueira, Rafael Delgado
medRxiv 2022.03.17.22272557; doi: https://doi.org/10.1101/2022.03.17.22272557
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
1
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (423)
- Allergy and Immunology (746)
- Anesthesia (219)
- Cardiovascular Medicine (3235)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13254)
- Forensic Medicine (19)
- Gastroenterology (891)
- Genetic and Genomic Medicine (5066)
- Geriatric Medicine (471)
- Health Economics (773)
- Health Informatics (3190)
- Health Policy (1129)
- Hematology (423)
- HIV/AIDS (1005)
- Medical Education (468)
- Medical Ethics (126)
- Nephrology (513)
- Neurology (4814)
- Nursing (254)
- Nutrition (716)
- Oncology (2484)
- Ophthalmology (703)
- Orthopedics (279)
- Otolaryngology (337)
- Pain Medicine (320)
- Palliative Medicine (89)
- Pathology (531)
- Pediatrics (1281)
- Primary Care Research (550)
- Public and Global Health (7375)
- Radiology and Imaging (1670)
- Respiratory Medicine (971)
- Rheumatology (473)
- Sports Medicine (416)
- Surgery (534)
- Toxicology (69)
- Transplantation (233)
- Urology (199)